glaucoma
New five-year data for MIGS device
Half a decade of data on the second generation iStent inject has shown a significant reduction in intraocular pressure (IOP) ...
Aussie study offers new MIGS head-to-head comparison
Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no ...
$300k grant to commercialise Aussie test for assessing glaucoma risk
A pioneering solution for assessing glaucoma risk in clinical settings is closer to commercialisation with the support of a $304,000 ...
New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of ...
Glaucoma Australia launches 7 Sights in 7 Days challenge for World Glaucoma Week
Glaucoma Australia (GA) has launched a new initiative encouraging Australians to share a photo of “an amazing sight” every day ...
Alcon to acquire Hydrus Microstent MIGS device for AU$640 million
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma ...
New glaucoma imaging tech wins 2021 ‘Quinlivan’ Research Grant
A UNSW researcher from the university’s Graduate School of Biomedical Engineering has been awarded Glaucoma Australia (GA)’s ‘Quinlivan’ Research Grant ...
Home-based glaucoma management
Designs For Vision is now supplying the iCare HOME2 tonometer, which it says revolutionises glaucoma care by enabling patients to ...
Artificial intelligence: eyecare’s friend of foe?
Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – ...